UBS cut its price target on Oklo (NYSE: OKLO) to $41 from $55 on Friday, while maintaining a “Neutral” rating on the nuclear energy company.
The revised target sits well below the 12-month consensus Street estimate of $77.13, according to data from Koyfin, reflecting a notably cautious stance on current valuation.
Despite the cut, UBS acknowledged that Oklo remains well positioned to benefit from strong U.S. government support for advanced nuclear power development.
The brokerage also highlighted Oklo’s Eielson Air Force Base microreactor project and its participation in Department of Energy reactor programs as meaningful validation of the company’s technology.
The Department of the Air Force has selected Oklo as the intended awardee for its first microreactor pilot, a significant milestone that could accelerate the company’s path to commercial deployment.
Under a final contract, Oklo would design, build, own, and operate an Aurora nuclear powerhouse at Eielson Air Force Base in Alaska, selling electricity and heat to the base under a long-term agreement.
The project is expected to deliver at least 5 megawatts of electricity and steam for heating purposes, with site characterization already underway and operations targeted for the early 2030s, subject to regulatory approvals.
Oklo is also participating in the U.S. Department of Energy’s Reactor Pilot Program, which is designed to accelerate the testing and deployment of advanced nuclear technologies across the country.
In August, Oklo’s Groves Isotope Test Reactor in Texas achieved criticality under the program, meaning it successfully produced a sustained nuclear chain reaction, becoming the fifth DOE-authorized advanced reactor to reach that milestone this summer.
The test reactor is expected to support development of a future commercial version capable of producing isotopes for medicine, manufacturing, space exploration, and national security applications.
OKLO shares were up 1.3% in pre-market trading on Friday, though the stock has faced sustained pressure throughout the year, declining in six of the nine months so far in 2026.
The stock had fallen to a 52-week low earlier this month, and shares have now declined more than 50% year-to-date, reflecting broader investor skepticism around the company’s near-term revenue prospects.
Retail sentiment surrounding OKLO remained bearish over the past 24 hours, though at least one user pointed to the company’s longer-term fundamentals, saying “AI will make this company very exciting” in the years to come.
Government contract awards and continued regulatory progress on the Eielson project will likely be the most closely watched catalysts for any meaningful shift in analyst and investor sentiment.
